560: Real-world impact of lumacaftor/ivacaftor on pulmonary outcomes in children aged 6 to 11 with CF

2021 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []